Display options
Share it on

Iran J Basic Med Sci. 2011 Nov;14(6):560-7.

Effects of Low-dose Morphine on Nitric Oxide Concentration and Angiogenesis in Two-kidney One Clip Hypertensive Rats.

Iranian journal of basic medical sciences

Aliasghar Pourshanazari, Mohammad Allahtavakoli, Ghgholamhossein Hassanshahi

Affiliations

  1. Physiology and Pharmacology Research Centre, Rafsanjan University of Medical Sciences, Rafsanjan, Iran.

PMID: 23493527 PMCID: PMC3586858

Abstract

OBJECTIVES: We investigated the effects of low-dose morphine on nitric oxide (NO) and angiogenesis in two-kidney one clip hypertensive (2K1C) rats.

MATERIALS AND METHODS: MALE RATS WERE DIVIDED INTO TWO GROUPS: sham-clip operated and 2K1C. Each group subdivided into saline and morphine (3 mg/kg i.p. 8 weeks) groups. Blood pressure, heart rate, plasma renin activity (PRA), NO concentration and murine matrigel angiogenesis were evaluated.

RESULTS: Morphine had no effects on blood pressures and HR in sham normotensive rats but attenuated diastolic blood pressure (DBP) (P< 0.01) and mean arterial pressure (MAP) (P< 0.01) in 2K1C compared with saline. PRA level was significantly higher in 2K1C compared with sham groups (P< 0.01) but morphine decreased it in 2K1C compared with saline (P< 0.01). After clipping, NO in 2K1C hypertensive rats was decreased (P< 0.01) and morphine increased it compared with saline (P< 0.01). Morphine promoted angiogenesis in both sham (P< 0.01) and 2K1C (P< 0.0001) groups.

CONCLUSION: Low-dose morphine stimulated angiogenesis in two-kidney one clip hypertensive rats probably via NO pathways.

Keywords: Angiogenesis; Blood pressure; Morphine; Nitric oxide; Renin activity

References

  1. Anesthesiology. 2007 Mar;106(3):532-7 - PubMed
  2. J Pharmacol Exp Ther. 1990 May;253(2):646-54 - PubMed
  3. Hypertension. 1991 May;17(5):707-19 - PubMed
  4. J Biol Chem. 1998 May 15;273(20):12402-6 - PubMed
  5. Pharmacology. 2006;77(1):17-24 - PubMed
  6. Med Oncol. 2011 Dec;28(4):1264-72 - PubMed
  7. Curr Neurovasc Res. 2006 Aug;3(3):171-80 - PubMed
  8. J Mol Cell Cardiol. 1997 Jan;29(1):55-65 - PubMed
  9. J Leukoc Biol. 2004 Jun;75(6):1131-8 - PubMed
  10. J Res Med Sci. 2011 Mar;16(3):269-75 - PubMed
  11. Angiogenesis. 2004;7(3):193-201 - PubMed
  12. Circ Res. 2004 Apr 16;94(7):960-6 - PubMed
  13. J Pharmacol Exp Ther. 1995 Jan;272(1):1-7 - PubMed
  14. J Neuroimmunol. 2004 Jan;146(1-2):13-21 - PubMed
  15. J Clin Hypertens (Greenwich). 2008 Apr;10(4):304-10 - PubMed
  16. Exp Eye Res. 2009 Nov;89(5):660-4 - PubMed
  17. Hypertension. 1987 Jun;9(6 Pt 2):III193-7 - PubMed
  18. Clin Chem. 2003 Jan;49(1):32-40 - PubMed
  19. Hypertens Res. 2008 May;31(5):873-9 - PubMed
  20. Inflammation. 1994 Jun;18(3):293-9 - PubMed
  21. Int J Immunopharmacol. 2000 Aug;22(8):603-14 - PubMed
  22. Exp Eye Res. 2007 Jan;84(1):185-90 - PubMed
  23. Anesth Analg. 2008 Aug;107(2):686-92 - PubMed
  24. Am J Hypertens. 2003 Jan;16(1):11-20 - PubMed
  25. Nitric Oxide. 2001 Feb;5(1):62-71 - PubMed
  26. Acta Physiol (Oxf). 2009 Jun;196(2):193-222 - PubMed
  27. J Cereb Blood Flow Metab. 2001 Aug;21(8):937-44 - PubMed
  28. J Biol Chem. 1995 Dec 22;270(51):30290-3 - PubMed
  29. J Cardiovasc Pharmacol. 2010 Apr;55(4):300-7 - PubMed
  30. Regul Pept. 2001 Jun 15;99(2-3):87-92 - PubMed
  31. Surgery. 2003 Aug;134(2):336-44 - PubMed
  32. J Anesth. 2009;23(4):554-68 - PubMed
  33. Am J Physiol Heart Circ Physiol. 2003 Jul;285(1):H81-9 - PubMed
  34. Acta Physiol Scand. 2002 Jul;175(3):245-51 - PubMed
  35. J Hum Hypertens. 2010 Nov;24(11):713-20 - PubMed
  36. Pathophysiology. 2011 Jun;18(3):201-6 - PubMed
  37. Cancer Res. 2002 Aug 1;62(15):4491-8 - PubMed
  38. J Hypertens. 2005 Nov;23(11):2013-8 - PubMed
  39. J Biol Chem. 1998 Sep 4;273(36):23534-41 - PubMed
  40. Anesthesiology. 2009 Jan;110(1):166-81 - PubMed
  41. Gen Pharmacol. 1991;22(6):1077-9 - PubMed
  42. Nat Med. 2009 Jun;15(6):657-64 - PubMed
  43. Heart Fail Rev. 2002 Oct;7(4):347-58 - PubMed

Publication Types